<![CDATA[온코크로스 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=39915>Thu, 30 Apr 2026 09:15:04 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Oncocross and JW Pharmaceutical Team Up on AI-powered Drugs for Cancer and Regeneration]]>https://www.newswire.co.kr/newsRead.php?no=990506Tue, 28 May 2024 14:58:55 +0900<![CDATA[Oncocross Completes Phase 1 Global Clinical Trial of OC514, Treatment for Sarcopenia]]>https://www.newswire.co.kr/newsRead.php?no=966698Thu, 11 May 2023 13:29:11 +0900<![CDATA[Oncocross Begins Phase I Clinical Trial of AI-Developed Drug for Sarcopenia]]>https://www.newswire.co.kr/newsRead.php?no=940205Mon, 28 Feb 2022 09:49:11 +0900